Search

Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment

Journal: Current Drug Targets
Volume: 11 Issue: 8 Year: 2010 Page: 978-993
Author(s): Najam A. Sharif

Safety Considerations of the Use of Second Generation Antipsychotics in the Treatment of Major Depression: Extrapyramidal and Metabolic Side Effects

Journal: Current Drug Safety
Volume: 5 Issue: 3 Year: 2010 Page: 263-266
Author(s): Charles DeBattista, Kristina DeBattista

New Prospects for the Drug Treatment of Generalized Anxiety Disorder — A Systematic Review

Journal: Current Drug Therapy
Volume: 5 Issue: 2 Year: 2010 Page: 86-94
Author(s): Paul Glue, Alistair Loan, Chris Gale

Journal: Current Psychiatry Reviews
Volume: 6 Issue: 2 Year: 2010 Page: 114-121
Author(s): Jimmy Lee, Siow-Ann Chong

The Genetics of Obsessive-Compulsive Disorder

Journal: Current Psychiatry Reviews
Volume: 6 Issue: 2 Year: 2010 Page: 91-103
Author(s): Michael H. Bloch, Christopher Pittenger

Gene Expression Profiling in Rodent Models for Schizophrenia

Journal: Current Neuropharmacology
Volume: 8 Issue: 4 Year: 2010 Page: 382-393
Author(s): Jessica E. Van Schijndel, Gerard J.M. Martens

Dihydrobenzo[1,4]oxathiine: A Multi-Potent Pharmacophoric Heterocyclic Nucleus

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 915-928
Author(s): C. Viglianisi, S. Menichetti

Journal: Current Topics in Medicinal Chemistry
Volume: 10 Issue: 8 Year: 2010 Page: 768-778
Author(s): Charles A. Lunn

A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation

Journal: Current Neuropharmacology
Volume: 8 Issue: 3 Year: 2010 Page: 287-304
Author(s): Michele Fornaro, Davide Prestia, Salvatore Colicchio, Giulio Perugi